Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 01, 2019
Marken has announced the acquisition of PCX International based in Japan.
read more
Tuesday, September 11, 2018
Maravai LifeSciences announced plans to relocate and expand its TriLink BioTechnologies operations with the signing of a lease on a new facility in the Sorrento Valley area of San Diego.
read more
Mapi Pharma announced an additional investment from Mylan in support of continued study progress to bring to market in the U.S. Glatiramer Acetate Depot.
read more
Mapi Pharma announced it will dedicate capacity at its manufacturing facility to support the global effort to provide COVID-19 vaccination to Israel, the EU and globally.
read more
Tuesday, January 08, 2019
ValGenesis announced that a manufacturer of Oral Rehydration Salts has chosen ValGenesis's paperless Validation Lifecycle Management System to manage its validation lifecycle process.
read more
Preferred Experience Varies among Pharmaceutical Companies
read more
Thursday, January 22, 2015
As part of its rapidly expanding range of analytical tools for materials characterization, Malvern Instruments will showcase a new chromatography system and detectors at Pittcon 2015 (Mar 8th – 12th, New Orleans, USA). New additions to Malvern’s ...
read more
Malvern Panalytical and Concept Life Sciences have jointly launched Amplify Analytics - a new range of highly flexible services designed to help pharmaceutical companies rapidly identify those drug candidates that meet bioavailability and ...
read more
Wednesday, January 12, 2022
Malvern Panalytical announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company.
read more
Friday, November 14, 2014
Malvern’s rapidly growing analytical toolkit for all stages of the pharmaceutical and biopharmaceutical product lifecycle will be on show at this year’s AAPS Annual Meeting and Exposition, in San Diego, USA (San Diego Convention Center, 2 - 6 ...
read more
Wednesday, August 24, 2016
Mallinckrodt has entered into a definitive agreement under which it will sell its Nuclear Imaging business to IBA Molecular (IBAM), for approximately $690 million before tax impacts, including up-front and contingent consideration and the assumption ...
read more
Wednesday, December 27, 2017
Mallinckrodt and Sucampo Pharmaceuticals announced they have entered into an agreement under which Mallinckrodt will acquire Sucampo, including its commercial and development assets.
read more
Wednesday, April 04, 2018
Paul R. Carter and Anne C. Whitaker have experience in the branded pharmaceutical industry and will join the Mallinckrodt Board pending shareholder vote at the Annual General Meeting in May, 2018.
read more
Saturday, January 28, 2017
Mallinckrodt has closed the sale of its global Nuclear Imaging business to IBA Molecular (IBAM) for approximately $690 million before tax, including up-front and contingent considerations and the assumption of long-term obligations.
read more
Monday, December 11, 2017
Mallinckrodt has closed the acquisition of Ocera Therapeutics, a clinical stage biopharmaceutical company.
read more